BCR and chronic myelogenous leukemia, BCR-ABL1 positive: BCR‐ABL, the fusion kinase of B‐cell receptor (BCR) and c‐Abl resulting from the Philadelphia chromosome, is a driver gene in initiating chronic myeloid leukaemia (CML) and promoting the malignant progression of CML.6